Cargando…
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
Recombinant vesicular stomatitis virus (VSV)-fusion and hemagglutinin (FH) was developed by substituting the promiscuous VSV-G glycoprotein (G) gene in the backbone of VSV with genes encoding for the measles virus envelope proteins F and H. Hybrid VSV-FH exhibited a multifaceted mechanism of cancer-...
Autores principales: | Nagalo, Bolni Marius, Breton, Camilo Ayala, Zhou, Yumei, Arora, Mansi, Bogenberger, James M., Barro, Oumar, Steele, Michael B., Jenks, Nathan J., Baker, Alexander T., Duda, Dan G., Roberts, Lewis Rowland, Russell, Stephen J., Peng, Kah Whye, Borad, Mitesh J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437509/ https://www.ncbi.nlm.nih.gov/pubmed/32839735 http://dx.doi.org/10.1016/j.omto.2020.08.007 |
Ejemplares similares
-
Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?
por: Zhang, Yuguo, et al.
Publicado: (2022) -
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
por: Kleinlützum, Dina, et al.
Publicado: (2017) -
Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018) -
Oncolytic virotherapy in upper gastrointestinal tract cancers
por: Yokoda, Raquel, et al.
Publicado: (2018) -
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)